DZ2691A1 - Compositions insolubles pour contrôler le glucose sanguin. - Google Patents

Compositions insolubles pour contrôler le glucose sanguin.

Info

Publication number: DZ2691A1
Authority: DZ; Algeria
Prior art keywords: blood glucose; controlling blood; insoluble compositions; insoluble; compositions
Prior art date: 1997-12-23

Application number

DZ980301A

Other languages

English (en)

Inventor

Mark Alurence Brader

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-23

Filing date

1998-12-22

Publication date

2003-03-29

1998-12-22 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2003-03-29 Application granted granted Critical

2003-03-29 Publication of DZ2691A1 publication Critical patent/DZ2691A1/fr

Links

WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title 1
239000008280 blood Substances 0.000 title 1
210000004369 blood Anatomy 0.000 title 1
239000008103 glucose Substances 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DZ980301A 1997-12-23 1998-12-22 Compositions insolubles pour contrôler le glucose sanguin. DZ2691A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US6860197P	1997-12-23	1997-12-23
US8885998P	1998-06-11	1998-06-11
US10994098P	1998-11-25	1998-11-25

Publications (1)

Publication Number	Publication Date
DZ2691A1 true DZ2691A1 (fr)	2003-03-29

Family

ID=27371371

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ980301A DZ2691A1 (fr)	1997-12-23	1998-12-22	Compositions insolubles pour contrôler le glucose sanguin.

Country Status (24)

Country	Link
US (2)	US6531448B1 (fr)
EP (1)	EP0925792B1 (fr)
JP (1)	JP2001526225A (fr)
KR (1)	KR20010024799A (fr)
CN (1)	CN1284876A (fr)
AR (1)	AR019807A1 (fr)
AT (1)	ATE264690T1 (fr)
AU (1)	AU2008899A (fr)
BR (1)	BR9814471A (fr)
CA (1)	CA2315300A1 (fr)
CO (1)	CO4970787A1 (fr)
DE (1)	DE69823319D1 (fr)
DZ (1)	DZ2691A1 (fr)
EA (1)	EA003394B1 (fr)
HR (1)	HRP20000427A2 (fr)
HU (1)	HUP0100243A3 (fr)
ID (1)	ID25476A (fr)
IL (1)	IL136724A0 (fr)
NO (1)	NO20003269L (fr)
NZ (1)	NZ505091A (fr)
PE (1)	PE20000106A1 (fr)
PL (1)	PL341300A1 (fr)
TR (1)	TR200001935T2 (fr)
WO (1)	WO1999032116A1 (fr)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0911035A3 (fr) *	1997-10-24	2002-08-21	Eli Lilly And Company	Compositions non solubles d' insuline
CO4970787A1 (es) *	1997-12-23	2000-11-07	Lilly Co Eli	Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
US6734162B2 (en)	2000-01-24	2004-05-11	Minimed Inc.	Mixed buffer system for stabilizing polypeptide formulations
US6737401B2 (en)	2001-06-28	2004-05-18	Metronic Minimed, Inc.	Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
WO2003020201A2 (fr)	2001-08-28	2003-03-13	Eli Lilly And Company	Pre-melanges de polypeptide glp-1 et d'insuline basale
EP1448222A4 (fr)	2001-10-19	2006-05-17	Lilly Co Eli	Melanges biphasiques de glp-1 et d'insuline
WO2003053460A1 (fr) *	2001-12-19	2003-07-03	Eli Lilly And Company	Compositions cristallines pour reguler la glycemie
WO2003059253A2 (fr) *	2001-12-21	2003-07-24	Smithkline Beecham Corporation	Compositions et methodes servant a modifier la production de glucose
WO2003094956A1 (fr)	2002-05-07	2003-11-20	Novo Nordisk A/S	Preparations solubles comprenant de l'insuline monomere et de l'insuline acylee
DK1581251T3 (da)	2002-12-31	2016-06-27	Althea Tech Inc	Krystaller af humant væksthormon og fremgangsmåder til fremstilling deraf
EP1605967A1 (fr) *	2003-03-13	2005-12-21	Novo Nordisk A/S	Nouvelles preparations d'insuline nph
WO2004096854A2 (fr) *	2003-04-29	2004-11-11	Eli Lilly And Company	Analogues de l'insuline ayant une action prolongee
US20050054818A1 (en) *	2003-07-02	2005-03-10	Brader Mark Laurence	Crystalline compositions for controlling blood glucose
AU2004261353B2 (en) *	2003-08-05	2009-12-10	Novo Nordisk A/S	Novel insulin derivatives
CN101027318B (zh)	2004-07-19	2016-05-25	比奥孔有限公司	胰岛素-低聚物共轭物，制剂及其用途
AU2014200247B2 (en) *	2004-07-19	2015-05-14	Biocon Limited	Insulin-oligomer conjugates, formulations and uses thereof
PL373543A1 (pl) *	2005-03-10	2006-09-18	Instytut Biotechnologii i Antybiotyków	Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy
CA2618068C (fr)	2005-08-05	2016-02-16	Amgen Inc.	Formulations pharmaceutiques de proteine aqueuse stable ou d'anticorps et leur preparation
CN102755634A (zh) *	2005-08-29	2012-10-31	味之素株式会社	营养组合物
EP1969004B1 (fr) *	2005-12-28	2011-08-10	Novo Nordisk A/S	Compositions renfermant une insuline acylée et du zinc et procédé de fabrication des dites compositions
US8343914B2 (en) *	2006-01-06	2013-01-01	Case Western Reserve University	Fibrillation resistant proteins
WO2007121318A2 (fr) *	2006-04-12	2007-10-25	Emisphere Technologies, Inc.	Préparations destinées à l'administration d'insuline
CN101573133B (zh)	2006-07-31	2014-08-27	诺沃-诺迪斯克有限公司	Peg化延长的胰岛素
CN101541830A (zh)	2006-09-22	2009-09-23	诺沃-诺迪斯克有限公司	蛋白酶抗性的胰岛素类似物
EP2074140B8 (fr) *	2006-10-04	2015-10-28	Case Western Reserve University	Insuline et analogues de l'insuline résistants à la fibrillation
WO2008132224A2 (fr)	2007-04-30	2008-11-06	Novo Nordisk A/S	Procédé de déshydratation d'une composition de protéine, composition de protéine déshydratée et composition pharmaceutique contenant la protéine déshydratée
JP5552046B2 (ja)	2007-06-13	2014-07-16	ノボ・ノルデイスク・エー／エス	インスリン誘導体を含有する薬学的製剤
US9241908B2 (en) *	2007-10-16	2016-01-26	Biocon Limited	Orally administrable solid pharmaceutical composition and a process thereof
CN101861333A (zh)	2007-11-16	2010-10-13	诺沃-诺迪斯克有限公司	包含glp-1肽或毒蜥外泌肽-4和基础胰岛素肽的药物组合物
CN101970477B (zh)	2008-03-14	2014-12-31	诺沃-诺迪斯克有限公司	蛋白酶稳定的胰岛素类似物
HUE032284T2 (en)	2008-03-18	2017-09-28	Novo Nordisk As	Protease-stabilized, acylated insulin analogues
EP2282763B1 (fr) *	2008-04-07	2013-12-11	National Institute Of Immunology	Procédé de préparation d'ensembles supramoléculaires de la calcitonine
WO2009129250A2 (fr) *	2008-04-14	2009-10-22	Case Western Reserve University	Analogues de l'insuline à prendre au moment des repas de stabilité améliorée
AU2009240636A1 (en) *	2008-04-22	2009-10-29	Case Western Reserve University	Isoform-specific insulin analogues
US9200053B2 (en)	2008-07-31	2015-12-01	Case Western Reserve University	Insulin analogues containing penta-fluoro-Phenylalanine at position B24
KR20120129875A (ko)	2008-07-31	2012-11-28	케이스 웨스턴 리저브 유니버시티	염소화 아미노산을 갖는 인슐린 유사체
EP2344200A2 (fr) *	2008-09-19	2011-07-20	Nektar Therapeutics	Peptides thérapeutiques modifiés, procédés pour les préparer et les utiliser
CN102202683A (zh) *	2008-10-30	2011-09-28	诺沃-诺迪斯克有限公司	用少于每日一次的注射频率注射胰岛素来治疗糖尿病
US8399407B2 (en) *	2009-09-17	2013-03-19	Case Western Reserve University	Non-standard insulin analogues
CN102770152B (zh)	2009-11-25	2016-07-06	阿瑞斯根股份有限公司	肽类的粘膜递送
RU2012123642A (ru)	2009-12-11	2014-01-20	Кейз Вестерн Ризев Юнивесити	Аналоги инсулина, содержащие хлорированные аминокислоты
DK2632478T3 (da)	2010-10-27	2019-10-07	Novo Nordisk As	Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller
CN102219851B (zh) *	2011-05-09	2012-05-30	甘李药业有限公司	甘精胰岛素结晶的制备方法
EP2720711A1 (fr) *	2011-06-15	2014-04-23	Novo Nordisk A/S	Insulines à substitutions multiples
EP2836508B1 (fr)	2012-04-11	2016-06-29	Novo Nordisk A/S	Formulations à base d'insuline
GB2513805B (en) *	2012-04-18	2020-04-01	Waters Technologies Corp	Methods for quantifying polypeptides using mass spectrometry
EP2844274B1 (fr)	2012-05-01	2019-03-20	Novo Nordisk A/S	Composition pharmaceutique
US9171343B1 (en)	2012-09-11	2015-10-27	Aseko, Inc.	Means and method for improved glycemic control for diabetic patients
US9897565B1 (en)	2012-09-11	2018-02-20	Aseko, Inc.	System and method for optimizing insulin dosages for diabetic subjects
US10421795B2 (en)	2012-12-17	2019-09-24	Merck Sharp & Dohme Corp.	Process for purifying insulin and analogues thereof
MX360420B (es) *	2012-12-19	2018-10-31	Wockhardt Ltd	Una composicion acuosa estable que comprende insulina humana o un analogo o derivado de la misma.
EP2948166B1 (fr) *	2013-01-22	2020-12-09	Case Western Reserve University	Analogues d'insuline tronqués à leur extrémité n-terminale
CN103145829B (zh) *	2013-03-29	2015-06-03	江苏诺泰制药有限公司	一种地特胰岛素的纯化方法
EP2991672A1 (fr)	2013-04-30	2016-03-09	Novo Nordisk A/S	Schéma d'administration d'un nouveau type
CA2926701A1 (fr)	2013-10-07	2015-04-16	Novo Nordisk A/S	Nouveau derive d'un analogue de l'insuline
US9898585B2 (en)	2014-01-31	2018-02-20	Aseko, Inc.	Method and system for insulin management
US9486580B2 (en)	2014-01-31	2016-11-08	Aseko, Inc.	Insulin management
AR099569A1 (es)	2014-02-28	2016-08-03	Novo Nordisk As	Derivados de insulina y los usos médicos de estos
AU2015328222B9 (en)	2014-10-06	2020-12-24	Case Western Reserve University	Biphasic single-chain insulin analogues
JP6989262B2 (ja)	2014-10-27	2022-01-05	アセコーインコーポレイテッド	皮下外来患者管理
US11081226B2 (en)	2014-10-27	2021-08-03	Aseko, Inc.	Method and controller for administering recommended insulin dosages to a patient
EP3337402B1 (fr)	2015-08-20	2026-01-07	Glytec, LLC	Conseiller de thérapie pour la gestion du diabète
ES2886837T3 (es)	2016-12-16	2021-12-21	Novo Nordisk As	Composiciones farmacéuticas que contienen insulina
US10335464B1 (en)	2018-06-26	2019-07-02	Novo Nordisk A/S	Device for titrating basal insulin
CN114096269B (zh)	2019-07-12	2024-06-11	诺和诺德股份有限公司	高浓度胰岛素制剂
KR102253318B1 (ko) *	2020-06-02	2021-05-18	(주)위바이오트리	금속 상 변환 화합물 및 이의 제조 방법
CN114306577B (zh) *	2020-10-10	2024-04-09	南京汉欣医药科技有限公司	一种门冬胰岛素30混悬液的制备方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2538018A (en)	1944-04-04	1951-01-16	Nordisk Insulinlab	Crystalline product of insulin and alkaline protein and process of making it
US2801953A (en)	1952-02-28	1957-08-06	Hoechst Ag	Process of preparing crystallized insulin preparations
US2849370A (en)	1953-06-04	1958-08-26	Novo Terapeutisk Labortorium A	Injectable insulin preparations with protracted effect and process of producing same
US3102077A (en)	1953-08-19	1963-08-27	Christensen Henry Marinus	Preparation of insulin containing 2.75 to 8 percent zinc content
US3060093A (en)	1957-07-18	1962-10-23	Nordisk Insulinlab	Slowly acting insulin preparation in crystalline form and method of preparation
US3012077A (en) *	1960-03-11	1961-12-05	Union Carbide Corp	Process for the production of organo sulfur compounds
DE1793517C3 (de)	1968-09-28	1974-12-05	Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt	N(Al),N(B29>Bis-(tert.-butyloxycarbonyl)-insulin und Verfahren zu seiner Herstellung
US3869437A (en)	1970-05-08	1975-03-04	Nat Res Dev	Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin
US3950517A (en)	1970-05-08	1976-04-13	National Research Development Corporation	Insulin derivatives
GB1381274A (en)	1971-01-28	1975-01-22	Nat Res Dev	Insulin derivatives
US3868358A (en)	1971-04-30	1975-02-25	Lilly Co Eli	Protamine-insulin product
US3864325A (en)	1971-11-18	1975-02-04	Nat Res Dev	(N{HU Al{b , N{HU Bl{b , N{HU B29{B , carbamoyl)-(O{HU A14{B , O{HU B16{B , O{HU B26{B aryl) insulin derivatives
US3907763A (en)	1972-03-01	1975-09-23	Bayer Ag	Insulin derivatives crosslinked by a dicarboxylic acid moiety
US4183849A (en)	1975-01-15	1980-01-15	Nordisk Insulinlaboratorium	Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect
JPS55138393A (en)	1979-04-13	1980-10-29	Shionogi & Co Ltd	Semisynthesis of insulin
JPS55138391A (en)	1979-04-13	1980-10-29	Shionogi & Co Ltd	New synthetic method of peptide derivative
IE50892B1 (en)	1980-02-11	1986-08-06	Novo Industri As	Process for preparing insulin esters
DE3101382A1 (de)	1981-01-17	1982-09-02	Hoechst Ag, 6000 Frankfurt	"verfahren zur herstellung von humanisulin oder dessen derivaten aus schweineinsulin oder dessen derivaten"
DK353781A (da)	1981-08-10	1983-02-11	Novo Industri As	Fremgangsmaade til fremstilling af insulinderivater
AU551174B2 (en)	1981-09-15	1986-04-17	Nordisk Insulinlaboratorium	Enzymatic preparation of human insulin or b-30 esters thereof
DE3326473A1 (de)	1983-07-22	1985-01-31	Hoechst Ag, 6230 Frankfurt	Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3327709A1 (de)	1983-07-29	1985-02-07	Hoechst Ag, 6230 Frankfurt	Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
PH25772A (en)	1985-08-30	1991-10-18	Novo Industri As	Insulin analogues, process for their preparation
DE3717370A1 (de)	1987-05-22	1988-12-01	Hoechst Ag	Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
JPH01254699A (ja)	1988-04-05	1989-10-11	Kodama Kk	インスリン誘導体及びその用途
WO1990001038A1 (fr)	1988-07-20	1990-02-08	Nordisk Gentofte A/S	Analogues d'insuline humaine et preparations les contenant
HUT56857A (en)	1988-12-23	1991-10-28	Novo Nordisk As	Human insulin analogues
IL93282A (en)	1989-02-09	1995-08-31	Lilly Co Eli	Insulin analogues
US5514646A (en)	1989-02-09	1996-05-07	Chance; Ronald E.	Insulin analogs modified at position 29 of the B chain
DK134189D0 (da)	1989-03-20	1989-03-20	Nordisk Gentofte	Insulinforbindelser
AT400337B (de) *	1990-05-02	1995-12-27	Plasser Bahnbaumasch Franz	Gleisstopfmaschine mit in gleisquerrichtung verstellbaren stopfeinheiten
EP0705275B1 (fr)	1993-06-21	1999-02-03	Novo Nordisk A/S	Cristaux d'insuline asp-b28
DK72793D0 (da)	1993-06-21	1993-06-21	Novo Nordisk As	Nyt produkt
US5534488A (en) *	1993-08-13	1996-07-09	Eli Lilly And Company	Insulin formulation
NZ273285A (en)	1993-09-17	1997-10-24	Novo Nordisk As	Insulin derivatives and compositions thereof
US5474978A (en)	1994-06-16	1995-12-12	Eli Lilly And Company	Insulin analog formulations
US5461031A (en)	1994-06-16	1995-10-24	Eli Lilly And Company	Monomeric insulin analog formulations
US5597893A (en)	1994-10-31	1997-01-28	Eli Lilly And Company	Preparation of stable insulin analog crystals
CA2215694A1 (fr)	1995-03-17	1996-09-26	Novo Nordisk A/S	Derives de l'insuline
US5700904A (en)	1995-06-07	1997-12-23	Eli Lilly And Company	Preparation of an acylated protein powder
US5877153A (en)	1996-06-11	1999-03-02	Commonwealth Biotechnologies Inc.	Heparin-binding peptides
CA2258099A1 (fr)	1996-06-20	1997-12-24	Novo Nordisk A/S	Preparations a base d'insuline contenant des glucides
US5948751A (en)	1996-06-20	1999-09-07	Novo Nordisk A/S	X14-mannitol
ATE294189T1 (de)	1997-02-07	2005-05-15	Novo Nordisk As	Kristallisation von proteinen
US5898028A (en)	1997-03-20	1999-04-27	Novo Nordisk A/S	Method for producing powder formulation comprising an insulin
HUP0004169A3 (en) *	1997-10-24	2001-06-28	Lilly Co Eli	Insoluble insulin compositions and process for production thereof
ZA989744B (en)	1997-10-31	2000-04-26	Lilly Co Eli	Method for administering acylated insulin.
CO4970787A1 (es) *	1997-12-23	2000-11-07	Lilly Co Eli	Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea

1998
- 1998-12-21 CO CO98075716A patent/CO4970787A1/es unknown
- 1998-12-21 US US09/217,275 patent/US6531448B1/en not_active Expired - Fee Related
- 1998-12-22 HR HR20000427A patent/HRP20000427A2/hr not_active Application Discontinuation
- 1998-12-22 PL PL98341300A patent/PL341300A1/xx unknown
- 1998-12-22 HU HU0100243A patent/HUP0100243A3/hu unknown
- 1998-12-22 KR KR1020007006946A patent/KR20010024799A/ko not_active Withdrawn
- 1998-12-22 NZ NZ505091A patent/NZ505091A/xx unknown
- 1998-12-22 EA EA200000708A patent/EA003394B1/ru not_active IP Right Cessation
- 1998-12-22 WO PCT/US1998/027299 patent/WO1999032116A1/fr not_active Ceased
- 1998-12-22 JP JP2000525107A patent/JP2001526225A/ja not_active Withdrawn
- 1998-12-22 CA CA002315300A patent/CA2315300A1/fr not_active Abandoned
- 1998-12-22 AU AU20088/99A patent/AU2008899A/en not_active Abandoned
- 1998-12-22 DZ DZ980301A patent/DZ2691A1/fr active
- 1998-12-22 BR BR9814471-5A patent/BR9814471A/pt not_active IP Right Cessation
- 1998-12-22 TR TR2000/01935T patent/TR200001935T2/xx unknown
- 1998-12-22 CN CN98813743A patent/CN1284876A/zh active Pending
- 1998-12-22 IL IL13672498A patent/IL136724A0/xx unknown
- 1998-12-22 PE PE1998001271A patent/PE20000106A1/es not_active Application Discontinuation
- 1998-12-22 ID IDW20001227A patent/ID25476A/id unknown
- 1998-12-22 AR ARP980106619A patent/AR019807A1/es unknown
- 1998-12-23 DE DE69823319T patent/DE69823319D1/de not_active Expired - Lifetime
- 1998-12-23 EP EP98310695A patent/EP0925792B1/fr not_active Expired - Lifetime
- 1998-12-23 AT AT98310695T patent/ATE264690T1/de not_active IP Right Cessation
2000
- 2000-06-22 NO NO20003269A patent/NO20003269L/no not_active Application Discontinuation
2003
- 2003-01-07 US US10/338,101 patent/US20030144181A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NZ505091A (en)	2002-11-26
PE20000106A1 (es)	2000-02-09
AU2008899A (en)	1999-07-12
IL136724A0 (en)	2001-06-14
TR200001935T2 (tr)	2000-12-21
JP2001526225A (ja)	2001-12-18
EP0925792A3 (fr)	2001-09-12
HRP20000427A2 (en)	2001-06-30
CO4970787A1 (es)	2000-11-07
PL341300A1 (en)	2001-04-09
ID25476A (id)	2000-10-05
NO20003269D0 (no)	2000-06-22
EA003394B1 (ru)	2003-04-24
KR20010024799A (ko)	2001-03-26
EA200000708A1 (ru)	2000-12-25
WO1999032116A1 (fr)	1999-07-01
BR9814471A (pt)	2000-10-10
CN1284876A (zh)	2001-02-21
AR019807A1 (es)	2002-03-20
DE69823319D1 (de)	2004-05-27
EP0925792B1 (fr)	2004-04-21
CA2315300A1 (fr)	1999-07-01
NO20003269L (no)	2000-08-23
US6531448B1 (en)	2003-03-11
EP0925792A2 (fr)	1999-06-30
US20030144181A1 (en)	2003-07-31
ATE264690T1 (de)	2004-05-15
HUP0100243A3 (en)	2001-09-28
HUP0100243A2 (hu)	2001-08-28

Publication	Publication Date	Title
IL136724A0 (en)	2001-06-14	Insoluble compositions for controlling blood glucose
ZA200200156B (en)	2003-05-19	Peptides that lower blood glucose levels.
ZA200108218B (en)	2003-03-26	Vascular surgery.
BR9816191B1 (pt)	2009-05-05	unidade de ampola/portador.
AU2937600A (en)	2000-09-28	Blood glucose level control
BR0014930B1 (pt)	2009-01-13	cÂnula.
DZ3001A1 (fr)	2004-03-27	Sel de potassium d'oméprazole-(S).
ZA9811339B (en)	1999-07-08	Benzamidine derivatives.
IT1305301B1 (it)	2001-05-04	Raccordo per anastomosi vascolari.
DZ2642A1 (fr)	2004-12-28	Hydrohalogénures 1'-Ä4-Ä1-(fluorphényl)-1h-indole-3ylÜ-1-butylÜ-spiroÄisobenzufuran-1(3h),4'-pipéridineÜ.
BR0012357B1 (pt)	2009-01-13	elevador de colheitas.
FR2761589B1 (fr)	1999-09-24	Catheter, notamment pour neurochirurgie
DK1149106T3 (da)	2003-07-14	4,5-azolo-oxindoler
FR2763498B1 (fr)	1999-08-20	Endoscope, en particulier mediastinoscope
BR0004161B1 (pt)	2011-11-29	solução de molho ácido.
FR2668697B1 (fr)	1997-06-06	Dissecteur, notamment pour chirurgie endoscopique.
ZA989644B (en)	2000-04-25	Insoluble insulen compositions.
ZA9811728B (en)	2000-06-27	Insoluble compositions for controlling blood glucose.
ZA969927B (en)	1998-05-26	2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives.
ES1039434Y (es)	1999-07-16	Estanteria.
ES1041880Y (es)	2000-01-01	Puya de picador.
FR2781516B1 (fr)	2000-09-15	Charniere pour elements articules, notamment des elements articules de mobilier
ITVC980018A0 (it)	1998-12-02	Biscotti "le risaiole".
ES1042496Y (es)	2000-02-01	"pilona sumible".
ZA9811387B (en)	1999-07-14	Improving ocular blood flow with brinzolamide.